Daniel Grosslight
Stock Analyst at Citigroup
(1.22)
# 3,764
Out of 5,242 analysts
147
Total ratings
33.7%
Success rate
-13.43%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Maintains: Buy | $145 → $112 | $80.36 | +39.37% | 2 | May 18, 2026 | |
| EVH Evolent Health | Maintains: Buy | $4 → $5.5 | $3.85 | +43.04% | 8 | May 15, 2026 | |
| AGL agilon health | Maintains: Neutral | $19 → $80 | $81.19 | -1.47% | 8 | May 15, 2026 | |
| PAHC Phibro Animal Health | Maintains: Neutral | $62 → $44 | $34.11 | +28.99% | 2 | May 14, 2026 | |
| MCK McKesson | Maintains: Buy | $975 → $945 | $753.64 | +25.39% | 9 | May 14, 2026 | |
| GDRX GoodRx Holdings | Maintains: Buy | $3.5 → $4 | $2.51 | +59.68% | 10 | May 14, 2026 | |
| ACH Accendra Health | Maintains: Buy | $3.25 → $5 | $2.69 | +86.22% | 2 | May 12, 2026 | |
| HIMS Hims & Hers Health | Maintains: Neutral | $24 → $28 | $22.86 | +22.48% | 15 | May 12, 2026 | |
| ELAN Elanco Animal Health | Maintains: Buy | $30 → $31 | $21.00 | +47.65% | 2 | May 7, 2026 | |
| COR Cencora | Maintains: Buy | $405 → $355 | $265.43 | +33.75% | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $30 | $19.18 | +56.41% | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $7 | $6.47 | +8.19% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $249 → $245 | $199.75 | +22.65% | 12 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $650 | $552.67 | +17.61% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $73.61 | +35.85% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $29 | $23.66 | +22.57% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $10 | $9.99 | +0.10% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $163.67 | +46.64% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $25 → $10 | $8.83 | +13.25% | 9 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.75 → $1.75 | $1.28 | +36.72% | 13 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $32 | $23.18 | +38.05% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $21 | $20.44 | +2.74% | 5 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $1.70 | +489.97% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $8.24 | -2.91% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $1.04 | +20.77% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $5.20 | -32.63% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.53 | +23.46% | 1 | Dec 11, 2019 |
Zoetis
May 18, 2026
Maintains: Buy
Price Target: $145 → $112
Current: $80.36
Upside: +39.37%
Evolent Health
May 15, 2026
Maintains: Buy
Price Target: $4 → $5.5
Current: $3.85
Upside: +43.04%
agilon health
May 15, 2026
Maintains: Neutral
Price Target: $19 → $80
Current: $81.19
Upside: -1.47%
Phibro Animal Health
May 14, 2026
Maintains: Neutral
Price Target: $62 → $44
Current: $34.11
Upside: +28.99%
McKesson
May 14, 2026
Maintains: Buy
Price Target: $975 → $945
Current: $753.64
Upside: +25.39%
GoodRx Holdings
May 14, 2026
Maintains: Buy
Price Target: $3.5 → $4
Current: $2.51
Upside: +59.68%
Accendra Health
May 12, 2026
Maintains: Buy
Price Target: $3.25 → $5
Current: $2.69
Upside: +86.22%
Hims & Hers Health
May 12, 2026
Maintains: Neutral
Price Target: $24 → $28
Current: $22.86
Upside: +22.48%
Elanco Animal Health
May 7, 2026
Maintains: Buy
Price Target: $30 → $31
Current: $21.00
Upside: +47.65%
Cencora
May 7, 2026
Maintains: Buy
Price Target: $405 → $355
Current: $265.43
Upside: +33.75%
May 5, 2026
Maintains: Buy
Price Target: $35 → $30
Current: $19.18
Upside: +56.41%
May 5, 2026
Maintains: Neutral
Price Target: $6 → $7
Current: $6.47
Upside: +8.19%
May 1, 2026
Maintains: Buy
Price Target: $249 → $245
Current: $199.75
Upside: +22.65%
Apr 15, 2026
Initiates: Neutral
Price Target: $650
Current: $552.67
Upside: +17.61%
Apr 15, 2026
Initiates: Buy
Price Target: $100
Current: $73.61
Upside: +35.85%
Apr 15, 2026
Initiates: Neutral
Price Target: $29
Current: $23.66
Upside: +22.57%
Apr 15, 2026
Initiates: Sell
Price Target: $10
Current: $9.99
Upside: +0.10%
Apr 15, 2026
Initiates: Buy
Price Target: $240
Current: $163.67
Upside: +46.64%
Mar 31, 2026
Downgrades: Neutral
Price Target: $25 → $10
Current: $8.83
Upside: +13.25%
Mar 13, 2026
Maintains: Neutral
Price Target: $2.75 → $1.75
Current: $1.28
Upside: +36.72%
Mar 3, 2026
Maintains: Buy
Price Target: $34 → $32
Current: $23.18
Upside: +38.05%
Feb 25, 2026
Maintains: Buy
Price Target: $63 → $21
Current: $20.44
Upside: +2.74%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $1.70
Upside: +489.97%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $8.24
Upside: -2.91%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $1.04
Upside: +20.77%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $5.20
Upside: -32.63%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $10.53
Upside: +23.46%